# Genome Medical Services, P.C.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/genome-medical-services-p-c

- Industry: Biotechnology
- Headquarters: San Francisco, US
- Website: www.genomemedical.com
- Total disclosed funding: $106M
- Latest round: Series C (Aug 30, 2021)
- Investors on record: 19

## About

Genome Medical Services, P.C. is a telehealth provider specializing in genetic services, offering expert genetic counseling, diagnostic support, and enhanced patient outcomes for those with rare diseases.Founded in 2016, Genome Medical Services, P.C. operates from San Francisco, US, providing telehealth-enabled genetic services. The company has engaged in five deals, with its most recent funding, a Series C round of USD 60.00 mn, completed on August 30, 2021, led by Casdin Capital. Co-founders Lisa Alderson, Robert Green, and Troy Kopischke, along with CEO Jill Davies, have experience in the life sciences sector, contributing to the firm’s growth and development.Genome Medical specializes in telehealth-enabled genetic services, providing expert guidance and improved outcomes for individuals with rare diseases. Core offerings include genetic counseling, genetic test ordering, clinical trial matching, and feasibility analysis. Collaborating with hospitals and health systems, the company serves a diverse clientele primarily in the United States while extending its services internationally, ensuring timely genetic care access.Genome Medical's revenue model is based on partnerships and direct patient services, engaging in B2B transactions with healthcare providers and direct-to-consumer interactions. The company collaborates with major commercial health insurance plans, facilitating coverage for its services. Its pricing structure includes fees for genetic counseling sessions and tests ordered, focusing on accessible care for individuals facing barriers to genetic services.Following the USD 60.00 mn funding raised in Series C on August 30, 2021, Genome Medical plans to expand its team and develop its technology solutions, adding new tools to its platform. The company is looking to grow its market presence, specifically targeting new geographic regions to enhance accessibility to genetic services for a broader audience.

## Funding rounds

- Series C, Aug 30, 2021, $60M — Canaan Partners, Flywheel Ventures, LRVHealth, Amgen Ventures, GV, Kaiser Permanente Ventures, Casdin Capital, HealthInvest Equity Partners, Alumni Ventures Group, Revelation Partners, Perceptive Advisors, Illumina Ventures, Echo Health Ventures, Dreamers VC, Avestria Ventures, Blue Ivy Ventures
- Series B, Jul 1, 2020, $14M — Canaan Partners, Flywheel Ventures, LRVHealth, Kaiser Permanente Ventures, Casdin Capital, Manatt Digital Media Ventures, HealthInvest Equity Partners, Alumni Ventures Group, Revelation Partners, Perceptive Advisors, Samsung Strategy & Innovation Center, Illumina Ventures, Echo Health Ventures, Dreamers VC
- Series B, May 30, 2019, $23M — Canaan Partners, LRVHealth, Kaiser Permanente Ventures, Casdin Capital, Manatt Digital Media Ventures, HealthInvest Equity Partners, Perceptive Advisors, Illumina Ventures, GE Ventures, Echo Health Ventures, Dreamers VC
- Series A, May 25, 2017, $8M — Canaan Partners, Flywheel Ventures, HealthInvest Equity Partners, Illumina Ventures
- Seed, Nov 9, 2016, $0.4M — Canaan Partners, Flywheel Ventures, HealthInvest Equity Partners

## Investors

- Canaan Partners (https://capitalatlas.ai/funds/canaan-partners) — Seed, Series A, Series B, Series C
- Flywheel Ventures (https://capitalatlas.ai/funds/flywheel-ventures) — Seed, Series A, Series B, Series C
- HealthInvest Equity Partners (https://capitalatlas.ai/funds/healthinvest-equity-partners) — Seed, Series A, Series B, Series C
- Illumina Ventures (https://capitalatlas.ai/funds/illumina-ventures) — Series A, Series B, Series C
- LRVHealth (https://capitalatlas.ai/funds/lrvhealth) — Series B, Series C
- Kaiser Permanente Ventures (https://capitalatlas.ai/funds/kaiser-permanente-ventures) — Series B, Series C
- Casdin Capital (https://capitalatlas.ai/funds/casdin-capital) — Series B, Series C
- Manatt Digital Media Ventures (https://capitalatlas.ai/funds/manatt-digital-media-ventures) — Series B
- Perceptive Advisors (https://capitalatlas.ai/funds/perceptive-advisors) — Series B, Series C
- GE Ventures — Series B
- Echo Health Ventures (https://capitalatlas.ai/funds/echo-health-ventures) — Series B, Series C
- Dreamers VC (https://capitalatlas.ai/funds/dreamers-vc) — Series B, Series C
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Series B, Series C
- Revelation Partners (https://capitalatlas.ai/funds/revelation-partners) — Series B, Series C
- Samsung Strategy & Innovation Center (https://capitalatlas.ai/funds/samsung-strategy-innovation-center) — Series B
- Amgen Ventures (https://capitalatlas.ai/funds/amgen-ventures) — Series C
- GV (https://capitalatlas.ai/funds/gv) — Series C
- Avestria Ventures (https://capitalatlas.ai/funds/avestria-ventures) — Series C
- Blue Ivy Ventures — Series C